Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00365053 · OUTCOME

Overall Survival

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery · Source last updated 2018-06-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Months
Interval / dispersion
95% Confidence Interval
Time frame
Up to 3 years

What was measured

Estimated using the product-limit method of Kaplan and Meier.

Groups in this outcome

Treatment (Belinostat)

Patients receive PXD101 IV at 1000 mg/m2 over 30 minutes on days 1-5. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. belinostat: Given IV laboratory biomarker analysis: Correlative studies

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Belinostat)13

Reported measurements

Source class 1
Values in Months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Treatment (Belinostat)4.5Not reported2.35.3Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        2.3
        upper Limit
        5.3
        value
        4.5
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    units
    Participants
description
Estimated using the product-limit method of Kaplan and Meier.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients receive PXD101 IV at 1000 mg/m2 over 30 minutes on days 1-5. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. belinostat: Given IV laboratory biomarker analysis: Correlative studies
    id
    OG000
    title
    Treatment (Belinostat)
param Type
MEDIAN
reporting Status
POSTED
time Frame
Up to 3 years
title
Overall Survival
type
SECONDARY
unit Of Measure
Months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice